Digital Therapeutics and Wellness Market Outlook (2023 to 2033)

The digital therapeutics and wellness market is anticipated to experience a staggering CAGR of 14.6% from 2023 to 2033. The digital therapeutics and wellness market is anticipated to reach US$ 30,553.8 million by 2033, from US$ 7,797.6 million in 2023. There are a few significant factors that are estimated to propel the market growth including:

  • The cost-effectiveness of digital health technology for providers & patients.
  • Increasing demand for integrated healthcare systems & patient-centric care

Surging rate of occurrence of preventable chronic disorders, and accelerating government support for healthcare is expected to bolster market development.

Attributes Details
Digital Therapeutics and Wellness Market CAGR (2023 to 2033) 14.6%
Digital Therapeutics and Wellness Market CAGR (2018 to 2022) 12.5%
Digital Therapeutics and Wellness Market Size (2022) US$ 6,900.5 million
Digital Therapeutics and Wellness Market (2023) US$ 7,797.6 million
Digital Therapeutics and Wellness Market (2033) US$ 30,553.8 million

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Factors fueling the Digital Therapeutics and Wellness Market Growth?

The key factor expected to propel the growth of the digital therapeutics and wellness market during the forecast period is the increasing smartphone penetration in developed and developing countries.

Other significant reasons such as the cost-effectiveness of digital health technology for providers & patients and increasing demand for integrated healthcare systems & patient-centric care are also expected to boost the market growth over the analysis period. Moreover, a few more vital things that are estimated to contribute significantly toward digital therapeutics and wellness industry growth are:

  • Increasing incidence of preventable chronic diseases
  • Increase in government funding for healthcare
  • Increase in digitalization in industries

Key Reasons behind Limiting the Digital Therapeutics and Wellness Market?

There are some key reasons that are acting as obstacles and are hindering the market growth during the forecast period.

Some countries, such as the United States (with its Health Insurance Portability and Accountability Act (HIPAA) and the Health Information Technology for Economic and Clinical Health (HITECH) Act), have legislation focusing on the issue of data security. However, despite such federal initiatives, digital therapeutics users are subject to infringement and data breaching, which may restrain the growth of the digital therapeutics market.

Motivating people to use digital therapeutics and building their confidence is another factor that is expected to hamper the growth of the digital therapeutics and wellness industry. Moreover, the rise in concerns related to cyber threats and data security hinders market growth.

Sudip Saha
Sudip Saha

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Key Trends in Market?

According to Kepios, in April 2021, there were 4.27 billion internet users globally, which is over 60% of the global population. As this number increases, awareness about smart health tracking is expected to improve. Furthermore, supportive regulatory initiatives & early signs of reimbursement, and the increasing pervasiveness of chronic disorders are also anticipated to fuel the market growth.

The lack of skilled medical practitioners in developing regions highlights the importance of connected healthcare. Furthermore, developing countries like India and China lack proper standards and government regulations for digital health solutions, which offer huge potential to providers who cannot meet stringent standards set by the federal government in the United States. The patient-doctor ratio in these regions is also significantly high, necessitating alternative healthcare solutions.

China and India are also observing high adoption of smartphones and its associated technologies owing to its increasing affordability. Globally, these countries are the top two countries in terms of smartphone ownership. Furthermore, the increasing access to smart devices and the Internet has encouraged the development of health apps.

Government bodies in China and India are taking initiatives to improve HCIT infrastructure. For instance, in its five-year plan from 2015 to 2020, China aimed to improve healthcare quality by implementing HCIT solutions.

2018 to 2022 Digital Therapeutics and Wellness Market Outlook in Comparison to 2023 to 2033 Growth Forecast

The market observed CAGR of 12.5% in the historical period. In 2022, the market reached market size of US$ 6,900.5 million. Over the forecast period, the market is projected to expand at a momentum of 14.6% CAGR. In 2023, the market is projected to achieve US$ 7,797.6 million. By 2033, the market is slated to reach US$ 30,553.8 million.

Key factors propelling market development of digital therapeutics and wellness industry include:

  • Growing health awareness leading to cognizance pertaining to digital therapeutics and wellness among individuals and users
  • Surge in the usage and technological advancements in health apps
  • Heightened adoption of smartphones and advanced connectivity is expected to foster market growth

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Which is the Leading Type of Digital Therapeutics and Wellness Solution?

Segment Software
Market Share % (2022) 56.8%

According to FMI, on the basis of type, software represents a significant CAGR of 13.9% during the forecast period. The segment contributed 56.8% of the overall market share in 2022. The segment growth can be attributed to the increased adoption of advanced software technologies by the healthcare industry.

What is the Demand Outlook Based on Application?

Based on application, cardiovascular disease and hypertension represent a significant CAGR of 13.4% during the forecast period, owing to the increasing usage of apps based on cardiovascular disease and hypertension. For instance, Japan based CureApp introduced DTx app for hypertension, which reduces heart disease and stroke risks.

Which Region is Performing Notably in the Digital Therapeutics and Wellness Industry?

Regions CAGR
North America Market Size (2022) 29.5%
Europe Market Size (2022) 21.9%
The United States Market Size (2022) 18.6%
Germany Market Size (2022) 9.5%
Japan Market Size (2022) 3.9%
Australia Market Size (2022) 2.9%
China Market CAGR % (2023 to 2033) 13.2%
India Market CAGR % (2023 to 2033) 16.5%
The United Kingdom Market CAGR % (2023 to 2033) 15.1%

North America accounted for 29.5% of the overall market share in 2022. This regional growth is due to:

  • Increased use of digital health products
  • Favorable reimbursement scenarios that focus on improving quality of life through improved tracking & diagnostics.

High incidence rate of chronic disorders and geriatric population in North America are estimated to propel market development.

The demand for digital therapeutics and wellness in the United States is projected to reach a valuation of US$ 9.3 billion by 2033 with a CAGR of 14.1%. Asia Pacific region is expected to expand at a significant growth rate during the projected period. This high growth can be attributed to the increase in demand for effective healthcare, the rise in smartphone penetration, and improved access to the internet.

Growing demand for personal care devices and related services, as a result of increased government spending on healthcare, is another significant factor expected to accelerate market growth.

China is expected to reach a market size of more than US$ 1.7 billion in 2033, representing a CAGR of 13.2%, over the forecast period. Japan and the United Kingdom are expected to reach the market size of more than US$ 1.4 billion and US$ 1.1 billion in 2033, representing growth forecasts of 12.7% and 13.2% respectively, throughout the forecast period.

South Korea, on the other hand, is expected to reach a market size of more than US$ 827.8 million in 2033, representing a CAGR of 11.9%, during the forecast period.

Who are the Key Competitors in the Digital Therapeutics and Wellness Industry?

Noom, Livongo Health, Omada Health, WellDoc, Pear Therapeutics, Proteus Digital Health, Propeller Health, Akili Interactive Labs, Better Therapeutics, and Happify, among others, are the top companies in the market.

With a substantial digital therapeutics and wellness industry share, these main firms are concentrating on growing their consumer base in new countries. These businesses are making use of strategic collaboration initiatives to grow their market share and profits.

Small and mid-size businesses are conversely enhancing their market presence by penetrating new markets and getting new contracts. All this is facilitated by product innovations and technical developments.

Recent Developments

  • Welldoc (USA) came into a partnership with Dexacom (USA) in April 2021. The partnership assisted BlueStar with Dexcom G6 CGM, an individual platform aimed at people with Type 2 diabetes for enhanced health.
  • In March 2021, Pear Therapeutics (USA) partnered with Spectrum Health Systems (USA). Tufts Health Plan and Spectrum Health Systems announced a collaboration with Pear Therapeutics to test FDA-approved digital therapeutics to help people with substance use disorders and improve their recovery journeys. It is done by delivering solutions for improved treatment access and care innovation journeys by delivering solutions for improved treatment access and care innovation
  • In January 2020, Crossroads Treatment Centers (USA) collaborated with Pear Therapeutics (USA) to implement the company’s digital platform reSET-O to help patients with opioid abuse and addiction.

Key Players Operating in the Digital Therapeutics and Wellness Market

  • Noom
  • Livongo Health
  • Omada Health
  • WellDoc
  • Pear Therapeutics
  • Proteus Digital Health
  • Propeller Health
  • Akili Interactive Labs
  • Better Therapeutics
  • Happify
  • Kaia Health
  • Mango Health
  • Click Therapeutics
  • Canary Health

Scope of Digital Therapeutics and Wellness Market Report

Attributes Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ million for Value
Key Countries Covered The United States, Canada, Germany, the United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Northern Africa, and South Africa
Key Segments Covered Type, Application, and Region
Key Companies Profiled Noom; Livongo Health; Omada Health; WellDoc; Pear Therapeutics; Proteus Digital Health; Propeller Health; Akili Interactive Labs; Better Therapeutics; Happify; Kaia Health; Mango Health; Click Therapeutics; Canary Health
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Key Segments Covered in the Digital Therapeutics and Wellness Industry Study

Digital Therapeutics and Wellness by Type:

  • Software
  • Devices

Digital Therapeutics and Wellness by Application:

  • Cardiovascular Disease and Hypertension
  • Diabetes and Prediabetes
  • Obesity and Weight Loss
  • Smoking Cessation
  • Others

Digital Therapeutics and Wellness by Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • The Middle East and Africa

Frequently Asked Questions

What is the Growth Potential of the Market?

The growth potential of this market expands at a CAGR of 14.6% through 2033.

What is the Potential Opportunity of this Market?

The increasing prevalence of chronic diseases creates lucrative opportunities.

Who are the Key Market Players?

Noom, Livongo Health, and Omada Health are the key market players.

What is the Market Value in 2023?

The market valuation in 2023 is US$ 7,797.6 million

What Drives the Digital Therapeutics and Wellness Market Growth?

Increasing incidence of preventable chronic diseases drives market growth.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Investment Feasibility Matrix
    3.5. PESTLE and Porter’s Analysis
    3.6. Regulatory Landscape
        3.6.1. By Key Regions
        3.6.2. By Key Countries
    3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) Analysis By Type, 2018 to 2022
    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Type, 2023 to 2033
        5.3.1. Software
        5.3.2. Devices
    5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022
    5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022
    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
        6.3.1. Cardiovascular Disease and Hypertension
        6.3.2. Diabetes and Prediabetes
        6.3.3. Obesity and Weight Loss
        6.3.4. Smoking Cessation
        6.3.5. Others
    6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
    7.1. Introduction
    7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
    7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
        7.3.1. North America
        7.3.2. Latin America
        7.3.3. Europe
        7.3.4. South Asia
        7.3.5. East Asia
        7.3.6. Oceania
        7.3.7. MEA
    7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        8.2.1. By Country
            8.2.1.1. The USA
            8.2.1.2. Canada
        8.2.2. By Type
        8.2.3. By Application
    8.3. Market Attractiveness Analysis
        8.3.1. By Country
        8.3.2. By Type
        8.3.3. By Application
    8.4. Key Takeaways
9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        9.2.1. By Country
            9.2.1.1. Brazil
            9.2.1.2. Mexico
            9.2.1.3. Rest of Latin America
        9.2.2. By Type
        9.2.3. By Application
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Type
        9.3.3. By Application
    9.4. Key Takeaways
10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        10.2.1. By Country
            10.2.1.1. Germany
            10.2.1.2. United Kingdom
            10.2.1.3. France
            10.2.1.4. Spain
            10.2.1.5. Italy
            10.2.1.6. Rest of Europe
        10.2.2. By Type
        10.2.3. By Application
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Type
        10.3.3. By Application
    10.4. Key Takeaways
11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        11.2.1. By Country
            11.2.1.1. India
            11.2.1.2. Malaysia
            11.2.1.3. Singapore
            11.2.1.4. Thailand
            11.2.1.5. Rest of South Asia
        11.2.2. By Type
        11.2.3. By Application
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Type
        11.3.3. By Application
    11.4. Key Takeaways
12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        12.2.1. By Country
            12.2.1.1. China
            12.2.1.2. Japan
            12.2.1.3. South Korea
        12.2.2. By Type
        12.2.3. By Application
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Type
        12.3.3. By Application
    12.4. Key Takeaways
13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        13.2.1. By Country
            13.2.1.1. Australia
            13.2.1.2. New Zealand
        13.2.2. By Type
        13.2.3. By Application
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Type
        13.3.3. By Application
    13.4. Key Takeaways
14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        14.2.1. By Country
            14.2.1.1. GCC Countries
            14.2.1.2. South Africa
            14.2.1.3. Israel
            14.2.1.4. Rest of MEA
        14.2.2. By Type
        14.2.3. By Application
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Type
        14.3.3. By Application
    14.4. Key Takeaways
15. Key Countries Market Analysis
    15.1. USA
        15.1.1. Pricing Analysis
        15.1.2. Market Share Analysis, 2022
            15.1.2.1. By Type
            15.1.2.2. By Application
    15.2. Canada
        15.2.1. Pricing Analysis
        15.2.2. Market Share Analysis, 2022
            15.2.2.1. By Type
            15.2.2.2. By Application
    15.3. Brazil
        15.3.1. Pricing Analysis
        15.3.2. Market Share Analysis, 2022
            15.3.2.1. By Type
            15.3.2.2. By Application
    15.4. Mexico
        15.4.1. Pricing Analysis
        15.4.2. Market Share Analysis, 2022
            15.4.2.1. By Type
            15.4.2.2. By Application
    15.5. Germany
        15.5.1. Pricing Analysis
        15.5.2. Market Share Analysis, 2022
            15.5.2.1. By Type
            15.5.2.2. By Application
    15.6. United Kingdom
        15.6.1. Pricing Analysis
        15.6.2. Market Share Analysis, 2022
            15.6.2.1. By Type
            15.6.2.2. By Application
    15.7. France
        15.7.1. Pricing Analysis
        15.7.2. Market Share Analysis, 2022
            15.7.2.1. By Type
            15.7.2.2. By Application
    15.8. Spain
        15.8.1. Pricing Analysis
        15.8.2. Market Share Analysis, 2022
            15.8.2.1. By Type
            15.8.2.2. By Application
    15.9. Italy
        15.9.1. Pricing Analysis
        15.9.2. Market Share Analysis, 2022
            15.9.2.1. By Type
            15.9.2.2. By Application
    15.10. India
        15.10.1. Pricing Analysis
        15.10.2. Market Share Analysis, 2022
            15.10.2.1. By Type
            15.10.2.2. By Application
    15.11. Malaysia
        15.11.1. Pricing Analysis
        15.11.2. Market Share Analysis, 2022
            15.11.2.1. By Type
            15.11.2.2. By Application
    15.12. Singapore
        15.12.1. Pricing Analysis
        15.12.2. Market Share Analysis, 2022
            15.12.2.1. By Type
            15.12.2.2. By Application
    15.13. Thailand
        15.13.1. Pricing Analysis
        15.13.2. Market Share Analysis, 2022
            15.13.2.1. By Type
            15.13.2.2. By Application
    15.14. China
        15.14.1. Pricing Analysis
        15.14.2. Market Share Analysis, 2022
            15.14.2.1. By Type
            15.14.2.2. By Application
    15.15. Japan
        15.15.1. Pricing Analysis
        15.15.2. Market Share Analysis, 2022
            15.15.2.1. By Type
            15.15.2.2. By Application
    15.16. South Korea
        15.16.1. Pricing Analysis
        15.16.2. Market Share Analysis, 2022
            15.16.2.1. By Type
            15.16.2.2. By Application
    15.17. Australia
        15.17.1. Pricing Analysis
        15.17.2. Market Share Analysis, 2022
            15.17.2.1. By Type
            15.17.2.2. By Application
    15.18. New Zealand
        15.18.1. Pricing Analysis
        15.18.2. Market Share Analysis, 2022
            15.18.2.1. By Type
            15.18.2.2. By Application
    15.19. GCC Countries
        15.19.1. Pricing Analysis
        15.19.2. Market Share Analysis, 2022
            15.19.2.1. By Type
            15.19.2.2. By Application
    15.20. South Africa
        15.20.1. Pricing Analysis
        15.20.2. Market Share Analysis, 2022
            15.20.2.1. By Type
            15.20.2.2. By Application
    15.21. Israel
        15.21.1. Pricing Analysis
        15.21.2. Market Share Analysis, 2022
            15.21.2.1. By Type
            15.21.2.2. By Application
16. Market Structure Analysis
    16.1. Competition Dashboard
    16.2. Competition Benchmarking
    16.3. Market Share Analysis of Top Players
        16.3.1. By Regional
        16.3.2. By Type
        16.3.3. By Application
17. Competition Analysis
    17.1. Competition Deep Dive
        17.1.1. Noom
            17.1.1.1. Overview
            17.1.1.2. Product Portfolio
            17.1.1.3. Profitability by Market Segments
            17.1.1.4. Sales Footprint
            17.1.1.5. Strategy Overview
                17.1.1.5.1. Marketing Strategy
        17.1.2. Livongo Health
            17.1.2.1. Overview
            17.1.2.2. Product Portfolio
            17.1.2.3. Profitability by Market Segments
            17.1.2.4. Sales Footprint
            17.1.2.5. Strategy Overview
                17.1.2.5.1. Marketing Strategy
        17.1.3. Omada Health
            17.1.3.1. Overview
            17.1.3.2. Product Portfolio
            17.1.3.3. Profitability by Market Segments
            17.1.3.4. Sales Footprint
            17.1.3.5. Strategy Overview
                17.1.3.5.1. Marketing Strategy
        17.1.4. WellDoc
            17.1.4.1. Overview
            17.1.4.2. Product Portfolio
            17.1.4.3. Profitability by Market Segments
            17.1.4.4. Sales Footprint
            17.1.4.5. Strategy Overview
                17.1.4.5.1. Marketing Strategy
        17.1.5. Pear Therapeutics
            17.1.5.1. Overview
            17.1.5.2. Product Portfolio
            17.1.5.3. Profitability by Market Segments
            17.1.5.4. Sales Footprint
            17.1.5.5. Strategy Overview
                17.1.5.5.1. Marketing Strategy
        17.1.6. Proteus Digital Health
            17.1.6.1. Overview
            17.1.6.2. Product Portfolio
            17.1.6.3. Profitability by Market Segments
            17.1.6.4. Sales Footprint
            17.1.6.5. Strategy Overview
                17.1.6.5.1. Marketing Strategy
        17.1.7. Propeller Health
            17.1.7.1. Overview
            17.1.7.2. Product Portfolio
            17.1.7.3. Profitability by Market Segments
            17.1.7.4. Sales Footprint
            17.1.7.5. Strategy Overview
                17.1.7.5.1. Marketing Strategy
        17.1.8. Akili Interactive Labs
            17.1.8.1. Overview
            17.1.8.2. Product Portfolio
            17.1.8.3. Profitability by Market Segments
            17.1.8.4. Sales Footprint
            17.1.8.5. Strategy Overview
                17.1.8.5.1. Marketing Strategy
        17.1.9. Better Therapeutics
            17.1.9.1. Overview
            17.1.9.2. Product Portfolio
            17.1.9.3. Profitability by Market Segments
            17.1.9.4. Sales Footprint
            17.1.9.5. Strategy Overview
                17.1.9.5.1. Marketing Strategy
        17.1.10. Happify
            17.1.10.1. Overview
            17.1.10.2. Product Portfolio
            17.1.10.3. Profitability by Market Segments
            17.1.10.4. Sales Footprint
            17.1.10.5. Strategy Overview
                17.1.10.5.1. Marketing Strategy
        17.1.11. Kaia Health
            17.1.11.1. Overview
            17.1.11.2. Product Portfolio
            17.1.11.3. Profitability by Market Segments
            17.1.11.4. Sales Footprint
            17.1.11.5. Strategy Overview
                17.1.11.5.1. Marketing Strategy
        17.1.12. Mango Health
            17.1.12.1. Overview
            17.1.12.2. Product Portfolio
            17.1.12.3. Profitability by Market Segments
            17.1.12.4. Sales Footprint
            17.1.12.5. Strategy Overview
                17.1.12.5.1. Marketing Strategy
        17.1.13. Click Therapeutics
            17.1.13.1. Overview
            17.1.13.2. Product Portfolio
            17.1.13.3. Profitability by Market Segments
            17.1.13.4. Sales Footprint
            17.1.13.5. Strategy Overview
                17.1.13.5.1. Marketing Strategy
        17.1.14. Canary Health
            17.1.14.1. Overview
            17.1.14.2. Product Portfolio
            17.1.14.3. Profitability by Market Segments
            17.1.14.4. Sales Footprint
            17.1.14.5. Strategy Overview
                17.1.14.5.1. Marketing Strategy
18. Assumptions & Acronyms Used
19. Research Methodology
Recommendations

Healthcare

Therapeutic Drug Monitoring Market

April 2024

REP-GB-953

342 pages

Healthcare

Digital Therapeutics Market

May 2022

REP-GB-14780

300 pages

Explore Technology Insights

View Reports
Future Market Insights

Digital Therapeutics and Wellness Market

Schedule a Call